The Northeast's Leading Outsource Solution,     Specializing in Cardiovascular Services News Briefs

Test 100% of your Patients with 0% of the Headaches.		June 13, 2008 (SAN DIEGO, CA): – The Society of Vascular Ultrasound (SVU) announced today that Joseph P. Hughes, RVT, RVS, FSVU, et al Navix Diagnostix, Inc., Taunton, MA and Montefiore Medical Center, Bronx, NY., has been awarded the Oral Clinical Presentation Award for the presentation on "Risk Focused Screenings for Vascular Disease: One University Hospital's Experience". Each year, several papers are presented at the annual conference, this year having been held in San Diego, CA. Navix' risk focused screenings have identified over 25% of program participants with some form of peripheral arterial disease warranting further follow-up by a physician. The 30 minute screening is a painless non-invasive screening for carotid artery disease, abdominal aortic aneurysm and peripheral arterial disease and can save the life of an at-risk individual. Joseph P. Hughes, Assistant Vice President for Clinical Services at Navix noted "by screening an 'at-risk' population, we are more likely to find individuals in need of treatment than in some other screening programs offered nationwide." Some programs simply take all comers, regardless of age or risk factors, often resulting in far less than 5% of individuals in need of further follup up care. May 27, 2008 (PHILADELPHIA, PA): – Chestnut Hill Hospital, a 180 bed acute care hospital and member of the 132 hospital CHS system, began outsourcing its vascular ultrasound lab today, to Vascular Diagnostics Center (VDC), a Navix Diagnostix managed affiliate. Chestnut Hill Hospital determined the expertise provided by Navix was necessary to improve overall community health and facilitate the accurate and expeditious diagnosis of patients suffering from peripheral arterial disease. With over 2,000 studies performed annually, VDC will seek ICAVL accreditation and to improve the vascular lab's profitability, delivering high quality, efficient patient care. Mike Nussbaum, Regional Sale Manager for Navix commented, "It was clear when we first met with the senior leadership at Chestnut Hill Hospital that they saw value, both in terms of economic and clinical benefits by outsourcing to Navix. The surgical, clinical and administrative staff worked closely with Navix to transition the services from in-house to outsourcing within less than a one-week period." March 14, 2008 (HARTFORD, CT): – Saint Francis Hospital and Medical Center, a 617 bed acute care major teaching hospital, has announced the opening of the 4,600-square-foot Center for Advanced Wound Healing. The Center chose Navix Diagnostix, Inc. to provide a full service vascular ultrasound program to support their patients needs. The Center offers comprehensive wound treatment and therapies directed at recovery of lymphatic system function. "Wound healing is a complex biological process. When it doesn't occur as expected, it can require specialized treatment under the guidance of experienced wound care professionals," said Christopher Dadlez, President & CEO, Saint Francis Hospital and Medical Center. Navix' vascular lab provides critical assessment & diagnostic support for the treatment and the restoration of function for patients with long-standing wound problems. Vascular ultrasound service is also provided for the local community as well as for patients of the Mt. Sinai Rehabilitation Hospital, and the Hospital for Special Care, both tentants of the Mt. Sinai North Campus location. Founded in 1897, Saint Francis is a major teaching hospital and is the largest Catholic hospital in New England. January 9, 2008 (PROVIDENCE RI): - Navix continues to fuel top line growth, adding several new clients. When University Surgical Associates, the largest vascular surgery practice in Rhode Island needed to gear up volume in their vascular lab, they turned to Navix Diagnostix to provide staff & equipment. Within two weeks of contracting with Navix, the company was able to provide a registered vascular technologist (RVT) and ultrasound equipment on a 10 hour, 4 day-per-week schedule. University Surgeons are also having their patients seen at Navix' newly opened Atwood Cardiovascular Services Center in nearby Johnston, RI, providing same day services for University Surgical patients in the Johnston area. September 10, 2007 (AUNTMINNIE.COM): – A recent auntminnie.com article comments on the value of ultrasound screening programs. The article entitled “Screening opportunities boost ultrasound prospects” on September 10th, 2007 by Erik Ridley states that “Increased interest in screening examinations and early identification of disease offer an opportunity for expanded use of ultrasound," according to Dr. Edward Bluth of Ochsner Clinic Foundation in New Orleans. In recent years, increasing attention has been paid by the lay press on healthcare issues and, in particular, the value of early disease identification and the role of screening, Bluth said. As a result, a better-informed public has been demanding greater participation in their healthcare decisions, and requesting screening examinations for early identification of disease. Another trend looming over the next year or two is the public's understanding of the increasing amount of radiation exposure they're facing from radiographic screening examinations, he said. The role of ultrasound as a safe screening tool is just now being appreciated in the press. Possible screening tests with ultrasound currently include AAA screening, carotid stenosis screening, and ankle-brachial index (ABI) for peripheral vascular disease, Bluth said. August 13, 2007 (TAUNTON, MA): - Navix’ Vascular Early Detection Initiative (VEDI TM) results has exceeded expectations! In an analysis of two VEDI TM programs deployed in May of this year, Navix has found that these risk-focused, routine screenings have identified over 25% of program participants with some form of peripheral arterial disease warranting further follow-up by a physician. The 20 minute screening is a painless non-invasive screening for carotid artery disease, abdominal aorta aneurysm and peripheral arterial disease and can save the life of an at-risk individual. Bob Kane, Sr. Vice President of Clinical Services for Navix noted “by screening an ‘at-risk’ population, we are more likely to find individuals in need of treatment than in some other screening programs offered nationwide. Some programs simply take all comers, regardless of age and/or risk factors, often resulting in far less than 5% of individuals in need of further follow up care. Programs that do not yield strong results are seldom repeated. Navix clients implementing the VEDI TM program have seen significant disease that would otherwise have gone undetected in their community, and plan to provide screening as an ongoing part of their service.” July 2, 2007 (TAUNTON, MA): – Navix recently surpassed the 150,000 annual run-rate for non-invasive vascular procedures. This milestone was achieved by the addition of several new clients over the past 12 months, as well as the significant community outreach and physician marketing programs deployed by Navix on behalf of their client base. John Merry, Navix’ Marketing Manager commented “our clinical strength allows Navix to deliver superior diagnostic results. Our focus on marketing to the referring physician communities on behalf our clients has proven a large factor in ‘same-store’ growth for our clients vascular labs, and something they rely on from Navix. Our recent deployment of the Vascular Early Detection Initiative (VEDI TM), a routine risk-focused screening program is a consumer-based outreach program designed to further assist our clients in the identification and diagnosis of at-risk individuals.” Clients implementing the VEDI TM program have seen significant disease that would otherwise have gone undetected in their community, and plan to provide screening as an ongoing part of their service.” June 18, 2007 (TAUNTON, MA): - Navix is pleased to announce that Joseph (JP) Hughes, Assistant Vice President of Clinical Services for Navix Diagnostix was recently published along with his peers in a recent article in the Journal of Vascular Ultrasound. “We are proud to have JP on the team,” said Cheryl Ford, Navix’ President and CEO, “Navix is committed to supporting our employees efforts in the ongoing research for the diagnosis of peripheral arterial disease.” May 1, 2007 (PHILADELPHIA, PA): – Navix Diagnostix has record month signing three new vascular lab clients. Pennsylvania Vascular Associates, Thomas Jefferson University Physicians, and The Advanced Vein and Vascular Center, Inc. have joined the growing list of Navix vascular lab clients. Navix Diagnostix, Inc. provides cardiovascular diagnostic services to hospital and physician practices throughout the northeast U.S. “We have built a reputation as a top tier provider of vascular lab services, improving patient care and vascular program revenue and profitability for our clients. Our excellence in delivery combines highly trained vascular technologists with Navix’ proprietary protocols, delivering studies that speed the critical pathway to patient diagnosis, while reducing many expensive and unnecessary confirmatory diagnostic testing” said Robert Kane, Senior Vice President of Clinical Services for Navix. He added, “we are thrilled to have these organizations join the growing list of Navix clients.” March 5, 2007 (BRONX, NY): – Navix Diagnostix announced today that it has launched the a comprehensive risk-focused vascular screening program at a major teaching hospital client site in New York. Navix’ Vascular Early Detection Initiative (VEDI TM), is a routine, risk-focused screening program aimed at early detection for individuals most at risk for peripheral arterial disease (PAD). It is estimated a that 8 -12 million Americans are effected by PAD, including 20% of people over age 65, and those suffering from PAD are 3 times more likely to die of heart attack or stroke. Navix was responsible for one of the first ICAVL accredited screening programs deployed in the U.S.
Navix Diagnostix. All Rights Reserved Terms of Use |  Privacy Policy Web Design by Spade Technology